Correction of increased prostacyclin production in Bartter's syndrome by indomethacin.
D015121:6-Ketoprostaglandin F1 alpha; D000293:Adolescent; D000328:Adult; D001477:Bartter Syndrome / Q000188:drug therapy / Q000378:metabolism*; D002648:Child; D011464:Epoprostenol / Q000096:biosynthesis*; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000378:metabolism*; D007213:Indomethacin / Q000627:therapeutic use*; D008875:Middle Aged; D011453:Prostaglandins / Q000096:biosynthesis*; D011458:Prostaglandins E / Q000652:urine; D011460:Prostaglandins F / Q000652:urine; D013928:Thromboxane A2 / Q000096:biosynthesis; D013929:Thromboxane B2 / Q000652:urine
D011453:Prostaglandins; D011458:Prostaglandins E; D011460:Prostaglandins F; D013929:Thromboxane B2; D013928:Thromboxane A2; D015121:6-Ketoprostaglandin F1 alpha; D011464:Epoprostenol; D007213:Indomethacin